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Relationship between antioxidant capacity and angiotensin-converting enzyme 
inhibitory activity of papain-generated protein hydrolysates and peptides from 
palm kernel cake proteins
Abstract
Palm kernel cake (PKC) proteins were hydrolysed in the presence of seven proteolytic enzymes. 
The antioxidant and antihypertensive activities of each protein hydrolysate were evaluated. 
Papain-generated protein hydrolysate showed the highest antioxidant effects measured by 
radical scavenging activity (65%), iron (Fe)(II)-chelating activity (65%), and antihypertensive 
activity (71%). The results revealed a strong correlation between the antioxidant activity of 
the protein hydrolysates with angiotensin-converting enzyme (ACE) inhibitory activity (R2 
= 0.69 - 0.98), except for trypsin-generated hydrolysate (R2 = 0.22). The most potent protein 
hydrolysate was fractionated and profiled using reversed-phase high-performance liquid 
chromatography and isoelectric focusing; peptides were subsequently isolated and identified 
by tandem mass spectrometry. The individual peptides were evaluated for antihypertension 
potential. A positive correlation was identified between radical scavenging activity and Fe(II)-
chelating activity together and ACE inhibitory activity with R2 = 0.69 - 0.98. The findings 
indicate that there was a positive relationship between the antioxidant and antihypertensive 
activities of protein hydrolysates and bioactive peptides from PKC proteins.
Introduction
Palm kernel cake (PKC) is the main by-product 
of the palm oil extraction process and a rich source of 
protein. However, PKC has not been fully exploited 
as food protein even though the protein extraction 
technique has been established. In Malaysia, PKC is 
generated in large quantities, with approximately 2.5 
million tons/annum produced by palm oil mills. As 
such, PKC may be considered a reliable and feasible 
raw material source of food protein. In addition to its 
use in the manufacturing of cellulose, hemicellulose, 
and lignin, the use of PKC is limited at present to 
being a source of fibres for the animal feed industry. 
A number of epidemiological studies have 
indicated a potent inverse relationship between 
cardiovascular disease (CVD) and fruit- and 
vegetables-rich diets (Liu et al., 2002; Weisburger, 
2002; Dias, 2019). Other epidemiological studies 
have also shown evidence of an association between 
CVD and daily antioxidant intake (Gey et al., 1993; 
Bacchetti et al., 2019; Marhuenda et al., 2019; 
Steinbrecher, 1997; Franzini et al., 2012; Tinkel 
et al., 2012). Furthermore, the findings of multiple 
observational epidemiological studies indicate that 
foods rich in antioxidants are correlated with reduced 
incidence of CVD (Stanner et al., 2004; Núñez-
Córdoba and Martínez-González, 2011).
Oxidative stress and hypertension are important 
areas of interest in research and the manufacturing 
of functional foods. Antioxidants protect the body 
against oxidative damage, a hypothetical etiologic 
factor in human aging, and age-related diseases 
such as CVD. Therefore, it has been suggested that 
antioxidants might play an important role in the 
prevention of CVD and other chronic age-related 
diseases. Basic research has elucidated a potential 
mechanism by which antioxidants may decrease 
the risk of atherosclerosis. However, it remains 
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antioxidants and CVD, or whether other dietary or 
lifestyle factors are also implicated. The available data 
from current researches are insufficient to determine 
the risk-to-benefit ratio of antioxidant use. Moreover, 
only one large-scale trial of more than 10 years has 
been conducted with respect to antioxidant use, and 
the benefits reported in this trial may have been 
attributable to prolonged exposure to antioxidants. 
Therefore, the data currently available can neither 
prove nor disprove the value of antioxidant use 
(Gaziano, 1996; Small et al., 2018). 
There is no evidence to date to support a 
correlation between antioxidant activity and 
angiotensin converting enzyme (ACE) inhibitory 
activity of peptides, although Benzie and Tomlinson 
(1998) reported the antioxidant activity of ACE 
inhibitors using ferric reducing antioxidant power 
(FRAP) in vitro. Based on these findings, only the 
ACE inhibitor captopril has been shown to exhibit 
significant antioxidant activity, and an association 
between concentration and antioxidant power of 
captopril was indicated in both aqueous and ethanolic 
solutions.
To the best of our knowledge, no study to date 
has established a relationship between antioxidant 
activity and ACE inhibitory activity of protein 
hydrolysates and bioactive peptides. Therefore, the 
main objective of the present work was to evaluate 
the relationship between antioxidant activity and 
ACE inhibitory activity of protein hydrolysate and 
bioactive peptides generated from PKC proteins.
Materials and methods
Chemicals
Palm kernel cake (PKC) was purchased from 
My-4-Seasons, Malaysia. Proteases were purchased 
from Novozyme Co. (Nottingham, UK) and Sigma 
Aldrich (Munich, Germany). Other chemicals used 
in the present work were obtained from Fisher 
Scientific Co. (Georgia, US). 
PKC protein isolate preparation
PKC was defatted with petroleum ether for 8 h 
in a Soxhlet extractor, and solvent was removed by 
rotary vacuum evaporator. Next, the defatted PKC 
was dried in a ventilator overnight at 20°C. PKC 
protein isolate (PKCPI) was produced following 
the method of Arifin et al. (2009), with slight 
modifications. PKCPI was obtained by dispersing 15 
g DPKC in solution of NaOH (0.03 N) at a ratio of 
1:30 (w/v) and extracted by shaking for 2 h in a water 
bath shaker. Following filtration through Whatman 
filter paper, the pH of the supernatant was adjusted to 
3.5 (HCl 1 N), which is the isoelectric point of PKC 
protein. The precipitate was subsequently obtained 
by centrifugation at 10,000 g for 10 min, freeze-
dried, and stored at -80°C until further use.
Preparation of PKC protein hydrolysates
PKC protein was hydrolysed following the method 
described by Zarei et al. (2015). PKC protein isolate 
was subsequently mixed with proteases including 
alcalase, papain, pepsin, trypsin, chymotrypsin, 
flavourzyme, and bromelain in a water bath shaker at 
the specific optimal conditions for each protease, and 
hydrolysed for 30 h under the conditions previously 
reported by Zarei et al. (2012). The reactions were 
terminated by heating the mixture in boiling water 
(100°C) for 10 min. After centrifugation (10,000 
g, 4°C, 10 min), supernatants were obtained for 
antioxidant and ACE inhibitory activity assays. 
DPPH• free radical scavenging assay
The 1,1-diphenyl-2-picrylhydrazyl (DPPH) 
free radical scavenging activity (RSA) assay was 
performed following the method described by 
Zarei et al. (2016) and Lee et al. (2010), with slight 
modifications. Briefly, peptide solution was mixed 
with deionised water and DPPH•. The mixture was 
kept in the dark, and the absorbance at 517 nm 
was measured using a 96-well microplate reader 
(Labomed, model UVD-2950, USA). 
Iron-chelating activity assay
Iron-chelating activity was determined following 
the method of Decker and Welch (1990) and Zarei et 
al. (2014), with minor modifications. 
ACE inhibition assay
ACE inhibition was determined following 
the method of Cushman and Cheung (1971) and 
Forghani et al. (2016), with slight modifications. 
Briefly, proteolysate or peptide solution was added 
to a mixture containing borate buffer and NaCl. 
Next, ACE was added to the mixture, which was 
then incubated at 37°С for 60 min. The enzymatic 
reaction was stopped by the addition of 1 N HCl. The 
hippuric acid released by the reaction was reacted 
with pyridine and benzenesulphonyl chloride (BSC). 
The mixture was vortexed for 1 min and placed in an 
ice bath, after which 200 µL was transferred to wells 
of a 96-well plate, and absorbance read at λmax of 410 
nm. 
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Fractionation and characterisation of PKC protein 
hydrolysates
Fractionation using reversed phase high 
performance liquid chromatography
Papain-generated PKC protein hydrolysate was 
fractionated following the method of Zarei et al. 
(2012) using a C18 reversed-phase high-performance 
liquid chromatography (RP-HPLC) column to 
fractionate based on the hydrophobicity of peptides. 
Isoelectric focusing fractionation 
The next step of fractionation was performed 
according to the isoelectric point (pI) of peptides 
following the method described by Zarei et al. (2015). 
Peptide sequence identification using tandem mass 
spectrometry
Peptide sequences analysis was performed using 
a mass hybrid quadrupole-time of flight (Q-TOF) 
mass spectrometer following the method described 
by Zarei et al. (2014). 
Statistical analysis
Statistical analyses were performed using one-
way analysis of variance (ANOVA) followed by 
Tukey’s test to identify the differences between 
treatments at a 5% significant level, and Pearson’s 
correlation to determine the correlation between 
biological activities. All analyses were performed 
using Minitab version 16 (Minitab Inc., State College, 
PA, USA). 
Results and discussion
Bioactivities of papain-generated protein 
hydrolysates 
PKC proteins were hydrolysed with papain, 
alcalase, pepsin, trypsin, chymotrypsin, bromelain, 
and flavourzyme to generate antioxidant and ACE 
inhibitory protein hydrolysates. Papain was added 
to the PKC protein buffer systems in three stages, 
at 0 h, 6 h, and 12 h with an enzyme-to-substrate 
ratio of 1:50. The Fe(ІІ)-chelating activity and 
ACE inhibitory activity of all protein hydrolysates 
generated by papain markedly increased during the 
first 2 h of proteolysis, followed by a slow increase 
over the remaining hydrolysis time. The antioxidant 
activities and ACE inhibitory activities of the PKC 
protein hydrolysates were evaluated. As shown in 
Figure 1, papain-generated protein hydrolysates 
showed maximum antioxidant activity as measured 
by RSA, Fe(II)-chelating activity, and ACE inhibitory 
activity of 65%, 65%, and 71%, respectively, at 30 h 
of hydrolysis time. ACE inhibitory activity greatly 
varied from 54% to 71% based on the hydrolysis 
time, thus reflecting variations in protein cleavage 
sites by hydrolysis time which could affect the 
resulting hydrolysate compositions and, therefore, 
the ACE inhibitory activity. 
Correlation between ACE inhibitory activity and 
antioxidant activity of PKC protein hydrolysates
As shown in Figure 2, most of the RSA of PKC 
protein hydrolysates generated by different enzymes 
showed a positive correlation (R2) with the ACE 
activity ranging between 0.69 and 0.98, except for 
trypsin generated protein hydrolysate which did not 
show a significant positive correlation (R2 = 0.22), 
indicating that the bioactive peptides produced by 
trypsin are most likely not of low molecular weight 
(< 1,500 Da) and are not composed of hydrophobic 
Figure 1. Bioactivities and time course of palm kernel cake 
protein hydrolysates generated by different enzymes: (a) 
radical scavenging activity; (b) Fe(II)-chelating activity; 
and (c) ACE inhibitory activity.
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residues. Figure 3 shows the correlation between 
ACE inhibitory activity and chelating activity of 
PKC protein hydrolysates produced by different 
proteases. As shown, a positive correlation was 
identified between the ACE inhibitory activities and 
chelating activities, with R2 = 0.69 - 0.97 (Figures 
3a - g). Among all of the protein hydrolysates, the 
ACE inhibitory activities of papain, flavourzyme, 
and chymotrypsin protein hydrolysates (Figures 3c - 
e) increased almost linearly with extended chelating 
activity. The other protein hydrolysates exhibited the 
same correlation, although they reached a plateau at 
different degrees of hydrolysis.  
Few studies to date have examined the correlation 
between ACE inhibitory activity and antioxidant 
activity of protein hydrolysates generated from 
different protein sources in vitro and in vivo. However, 
some studies have demonstrated a relationship 
between CVD and antioxidant intake. In one report, 
individuals with a diet rich in fruit and vegetables or 
having a high plasma concentration of antioxidant 
micronutrients had a lower risk of stroke and CVD. 
The results of these studies indicate that high-risk 
populations with a high incidence of CVD, coronary 
heart disease, and stroke should increase their 
daily intake of dietary antioxidants. Furthermore, 
populations with low intakes of fruit and vegetables 
who follow this recommendation have subsequently 
been shown to have significantly increased plasma 
antioxidant concentrations (Szeto et al., 2004). 
In another study, antioxidants from pomegranate 
juice were shown to reduce blood pressure in 
hypertensive patients due to serum ACE inhibition, 
as these antioxidants can increase the activity of 
serum paraoxonase which can protect against lipid 
peroxidation (Aviram et al., 2001). Moreover, the 
common carotid intima–media thickness, blood 
pressure, and LDL oxidation were markedly reduced 
in these patients after pomegranate juice consumption 
for three years (Aviram et al., 2004). 
In addition, in a study performed by Benzie 
et al. (2002) on the antioxidant power of ACE 
inhibitors, captopril was shown to have significant 
antioxidant activity. The findings also demonstrated 
Figure 2. Function of radical scavenging activity (RSA) 
versus ACE inhibitory activity of PKC protein hydrolysates 
produced by different enzymes: (a) alcalase; (b) bromelain; 
(c) chymotrypsin; (d) flavourzyme; (e) papain; (f) pepsin; 
and (g) trypsin.
Figure 3. Function of Fe(II)-chelating activity versus ACE 
inhibitory activity of PKC protein hydrolysates produced 
by different enzymes: (a) alcalase; (b) bromelain; (c) 
chymotrypsin; (d) flavourzyme; (e) papain; (f) pepsin; and 
(g) trypsin.
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the concentration-dependent antioxidant activity of 
captopril in both aqueous and ethanolic solutions. 
Furthermore, a correlation was identified between 
PKC protein hydrolysates with higher DHs and 
ACE inhibitory activity and antioxidant activity 
with higher R2. This finding indicated that PKC 
protein hydrolysates, including peptides with lower 
molecular weights and more hydrophobic residues, 
could simultaneously exhibit ACE inhibitory and 
antioxidant activities.
Identification and characterisation of bioactive 
peptides from papain-generated protein hydrolysate
Bioactive peptide sequences
Table 1 shows the antioxidant and ACE 
inhibitory activity of PKC peptides generated from 
PKC proteins. All peptides showed antioxidant and 
ACE inhibitory activities that varied from 31% 
- 71% for RSA, 38% - 56% for Fe(II)-chelating 
activity, and 40% - 100% for ACE inhibitory activity. 
The peptides AWFS and GGIF showed the highest 
radical scavenging and Fe(II)-chelating activity 
(71% and 56%, respectively) while peptides YLLLK, 
YGIKVGYAIP and LPWRPATNVF showed the 
highest ACE inhibitory activity (all 100%). As 
shown, papain-generated bioactive peptides showed 
higher and more potent ACE inhibitory activities as 
compared to their antioxidant activities.
Correlation between radical scavenging activity, 
Fe(II)-chelating activity, and ACE inhibition of 
bioactive peptides
The antioxidant properties of peptides are 
attributable to their free-radical-scavenging, metal-
ion-chelating, and singlet-oxygen-quenching 
activities (Kitts and Weiler, 2003). The results of the 
structure–function relationships described in previous 
sections showed a close relationship between RSA, 
Fe(II)-chelating activity, and ACE inhibitory activity.
Figure 4 shows the relationship between the 
radical-scavenging activity and metal-chelating 
activity of biopeptides generated from PKC. As 
shown, the RSA increased with increasing metal-
chelating activity. All bioactive peptides followed a 
second-order polynomial model with R2 in the range 
of 0.74 - 0.97. 
The mechanism of correlation between radical-
scavenging activity and iron-chelating activity has 
not been previously reported, but it seems that the 
structure-function relationships of peptides could 
be the reason for the relationship between RSA and 
Fe(II)-chelating activity. As previous studies have 
shown (Xia et al., 2012; Guo et al., 2014), peptides 
with Phe, Tyr and Trp, Lys and Arg in their sequences 
show high chelating activity, and bioactive peptides 
having these amino acids in their structure (Wang and 
De Mejia, 2005) also show potent RSA. Furthermore, 
it has been previously reported that small peptides (< 
12 kDa) showed higher chelating activity and RSA 
than larger peptides, although smaller bioactive 
peptides (< 500 Da) had higher iron-chelating 
activities than peptides > 500 Da (Torres-Fuentes et 
al., 2012). Therefore, similarities in peptide structure 
appears to result in similar radical scavenging and 
metal-chelating activities.
Figure 5 shows the function of ACE inhibitory 
activity of peptides generated from PKC proteins 
versus RSA. The relationship between ACE 
















YLLLK 5 648.85 80 41 ± 1.11E 53 ± 1.00AB 100 ± 2.99A
YGIKVGYAIP 10 1080.29 60 44 ± 1.10DE 50 ± 1.42BC 100 ± 3.00A
GGIF 4 392.46 50 31 ± 0.69F 56 ± 1.56A 97 ± 2.18A
GIFE 4 462.52 50 31 ± 1.01F 41 ± 0.83D 40 ± 1.00E
WAFS 4 509.56 75 47 ± 1.10CD 38 ± 0.84D 55 ± 1.81D
GVQEGAGHYALL 12 1,214.34 50 36 ± 0.66F 41 ± 0.58D 70 ± 1.15C
WAF 3 422.48 100 56B ± 1.71B 47 ± 1.05C 94 ± 2.36A
AWFS 4 509.56 75 71 ± 2.22A 41 ± 1.08D 86 ± 2.58B
LPWRPATNVF 10 1,200.41 60 50 ± 1.93C 48 ± 1.05BC 100 ± 3.00A
Glutathione - - - 83 ± 2.81 - -
EDTA - - - - 96 ± 2.4 -
Captopril - - - - - 98 ± 2.73
Data are presented as mean ± SD of three replications (n = 3). Mean values within each row indicated with different superscript letters A–F are 
significantly different (p < 0.05).
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inhibitory activity and RSA also followed a second-
order polynomial model, with R2 between 0.69 
and 0.89. The ACE inhibitory activity of bioactive 
peptides increased with increasing RSA, although the 
ACE inhibitory activity of peptide YLLLK decreased 
with increasing RSA up to 40%, after which the ACE 
inhibitory activity gradually increased. 
It has been suggested that amino acid composition, 
peptide structure, and hydrophobicity are the most 
important factors affecting the antioxidant properties 
and ACE inhibitory activity of bio-peptides. 
Moreover, it has been indicated that cysteine, 
tryptophan, tyrosine, lysine, and methionine in the 
peptide sequence or at the C-terminal and Val or Leu 
at the N-terminal contribute to antioxidant potential 
and ACE inhibitory activity. Furthermore, aromatic 
residues are thought to enhance the antioxidant and 
ACE inhibitory activity of bio-peptides (Kitts and 
Weiler, 2003). 
The ACE inhibitory activity of antioxidant 
peptides can be attributed to the hydrophobic and 
aromatic residues of antioxidant bioactive peptides 
obtained from PKC proteins, which can bind with the 
active site of ACE as a hydrophobic active site. 
In comparison, previous studies have suggested 
that diets with high consumption of fruits and 
Figure 5. Function of ACE inhibitory activity versus 
radical scavenging activity (RSA) of bioactive peptides: 
(a) peptide 1; (b) peptide 2; (c) peptide 3; (d) peptide 4; (e) 
peptide 5; (f) peptide 6; (g) peptide 7; (h) peptide 8; and 
(i) peptide 9.
Figure 4. Function of radical scavenging activity (RSA) 
versus Fe(II)-chelating activity of bioactive peptides: (a) 
peptide 1; (b) peptide 2; (c) peptide 3; (d) peptide 4; (e) 
peptide 5; (f) peptide 6; (g) peptide 7; (h) peptide 8; and 
(i) peptide 9.
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vegetables are associated with moderately lower 
overall mortality rates and lower death rates from 
CVD and some types of cancer. The ‘antioxidant 
hypothesis’ proposes that vitamin C, carotenoids, 
vitamin E, and other antioxidants significantly 
increase protection against chronic diseases by 
reducing oxidative stress (Stanner et al., 2004).
Moreover, a number of epidemiological studies 
have indicated that the risk of CVD is markedly 
decreased with a diet rich in plant-based foods 
such as fruits and vegetables (Liu et al., 2002; 
Weisburger, 2002). Several epidemiological studies 
have also shown evidence of a positive correlation 
between CVD and antioxidant intake (Gey et al., 
1991; 1993), and multiple studies and reviews about 
the relationship between CVD and antioxidants 
have been published (Steinbrecher, 1997; Tinkel et 
al., 2012). Furthermore, a number of observational 
epidemiological studies support the hypothesis that 
the incidence of CVD in individuals with high daily 
antioxidant intake is meaningfully lower than in 
those with low daily antioxidant intake (Stanner et 
al., 2004).
Although no study to date has described a 
correlation between antioxidant activity and ACE 
inhibitory activity of bioactive peptides, Benzie and 
Tomlinson (1998) evaluated the antioxidant power 
of ACE inhibitors using FRAP in vitro. Based on 
their findings, only captopril was found to exhibit 
significant antioxidant power, and this effect was 
observed in both aqueous and ethanolic solutions.
Figure 6 shows the function of ACE inhibitory 
activity versus Fe(II)-chelating activity of bioactive 
peptides generated from PKC proteins. The correlation 
between ACE inhibitory activity and metal-chelating 
activity followed a second-order polynomial 
model, with an R2 between 0.5477 and 0.8743. The 
ACE inhibitory activity of peptides increased with 
increasing chelating activity of bioactive peptides. 
However, the ACE inhibitory activity of the peptides 
GIFE and GVQEGAGHYALL slightly decreased as 
chelating activity increased but gradually increased 
with a sharp slope (Figure 6d) and (Figure 6f).
Inhibitors of ACE include metal-chelating 
agents such as ethylenediaminetetraacetic acid, 
o-phenanthroline, and 8-OH-quinoline, and a number 
of synthetic pharmaceuticals and bioactive peptides 
(Wyvratt and Patchett, 1985; Murray and FitzGerald, 
2007). The high ACE inhibitory activity of some 
bioactive peptides might presumably relate to their 
ability to chelate metal in the zinc ligand of ACE 
(Kang et al., 2003; Qian et al., 2007). The results 
obtained in the present work thus confirm that there 
is a positive correlation between DPPH• RSA and 
metal-chelating activity with ACE inhibitory activity.
Conclusion
Seven enzymatic-protein hydrolysates were 
generated from PKC proteins; and were found to 
exhibit ACE inhibitory and antioxidant activities. 
Papain-generated protein hydrolysate showed the 
most potent ACE inhibitory and antioxidant activities 
among the various protein hydrolysates. Bioactive 
peptides were isolated and identified from papain-
generated PKC protein hydrolysate by tandem MS, 
and their respective antioxidant and antihypertensive 
Figure 6. Function of ACE inhibitory activity versus 
Fe(II)-chelating activity of bioactive peptides: (a) peptide 
1; (b) peptide 2; (c) peptide 3; (d) peptide 4; (e) peptide 5; 
(f) peptide 6; (g) peptide 7; (h) peptide 8; and (i) peptide 
9.
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activities were evaluated. The results showed a 
positive correlation between ACE inhibition and 
radical scavenging and Fe(II)-chelating activities, 
with R2 = 0.69 - 0.98 and R2 = 0.69 - 0.97, respectively. 
Furthermore, the ACE inhibitory and antioxidant 
activities of bioactive peptides were also shown to 
have a positive correlation. ACE inhibitory activity 
of antioxidant peptides appeared to be attributable to 
the hydrophobic and aromatic residues of antioxidant 
bioactive peptides obtained from PKC proteins, 
which could bind to the active site of ACE as a 
hydrophobic active site.
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